Open Access
Vet. Res.
Volume 41, Number 5, September–October 2010
Number of page(s) 12
Published online 29 April 2010
How to cite this article Vet. Res. (2010) 41:56
  • Blackburn E.H., Switching and signaling at the telomere, Cell (2001) 106:661–673. [CrossRef] [PubMed]
  • Calnek B.W., Marek’s disease – a model for herpesvirus oncology, Crit. Rev. Microbiol. (1986) 12:293–320. [CrossRef] [PubMed]
  • Calnek B.W., Pathogenesis of Marek’s disease virus infection, Curr. Top. Microbiol. Immunol. (2001) 255:25–55. [PubMed]
  • Davison A., Comments on the phylogenetics and evolution of herpesviruses and other large DNA viruses, Virus Res. (2002) 82:127–132. [CrossRef] [PubMed]
  • Davison A.J., Evolution of the herpesviruses, Vet. Microbiol. (2002) 86:69–88. [CrossRef] [PubMed]
  • Delany M.E., Krupkin A.B., Miller M.M., Organization of telomere sequences in birds: evidence for arrays of extreme length and for in vivo shortening, Cytogenet. Cell Genet. (2000) 90:139–145. [CrossRef] [PubMed]
  • Fragnet L., Blasco M.A., Klapper W., Rasschaert D., The RNA subunit of telomerase is encoded by Marek’s disease virus, J. Virol. (2003) 77:5985–5996. [CrossRef] [PubMed]
  • Fragnet L., Kut E., Rasschaert D., Comparative functional study of the viral telomerase RNA based on natural mutations, J. Biol. Chem. (2005) 280:23502–23515. [CrossRef] [PubMed]
  • Harley C.B., Futcher A.B., Greider C.W., Telomeres shorten during ageing of human fibroblasts, Nature (1990) 345:458–460. [CrossRef] [PubMed]
  • Harley C.B., Vaziri H., Counter C.M., Allsopp R.C., The telomere hypothesis of cellular aging, Exp. Gerontol. (1992) 27:375–382. [CrossRef] [PubMed]
  • Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., et al., Activation of telomerase in human lymphocytes and hematopoietic progenitor cells, J. Immunol. (1995) 155:3711–3715. [PubMed]
  • Jarosinski K.W., Osterrieder N., Nair V.K., Schat K.A., Attenuation of Marek’s disease virus by deletion of open reading frame RLORF4 but not RLORF5a, J. Virol. (2005) 79:11647–11659. [CrossRef] [PubMed]
  • Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., Osterrieder N., Horizontal transmission of Marek’s disease virus requires US2, the UL13 protein kinase, and gC, J. Virol. (2007) 81:10575–10587. [CrossRef] [PubMed]
  • Jones D., Lee L., Liu J.L., Kung H.J., Tillotson J.K., Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors, Proc. Natl. Acad. Sci. USA (1992) 89:4042–4046. [CrossRef]
  • Kamil J.P., Tischer B.K., Trapp S., Nair V.K., Osterrieder N., Kung H.J., vLIP, a viral lipase homologue, is a virulence factor of Marek’s disease virus, J. Virol. (2005) 79:6984–6996. [CrossRef] [PubMed]
  • Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al., Specific association of human telomerase activity with immortal cells and cancer, Science (1994) 266:2011–2015. [CrossRef] [PubMed]
  • Kingham B.F., Zelnik V., Kopacek J., Majerciak V., Ney E., Schmidt C.J., The genome of herpesvirus of turkeys: comparative analysis with Marek’s disease viruses, J. Gen. Virol. (2001) 82:1123–1135. [PubMed]
  • Levy A.M., Izumiya Y., Brunovskis P., Xia L., Parcells M.S., Reddy S.M., et al al., Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek’s disease virus-transformed T cells, J. Virol. (2003) 77:12841–12851. [CrossRef] [PubMed]
  • Levy A.M., Gilad O., Xia L., Izumiya Y., Choi J., Tsalenko A., et al., Marek’s disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses, Proc. Natl. Acad. Sci. USA (2005) 102:14831–14836. [CrossRef]
  • Lindsey J., McGill N.I., Lindsey L.A., Green D.K., Cooke H.J., In vivo loss of telomeric repeats with age in humans, Mutat. Res. (1991) 256:45–48. [PubMed]
  • Lupiani B., Lee L.F., Cui X., Gimeno I., Anderson A., Morgan R.W., et al., Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication, Proc. Natl. Acad. Sci. USA (2004) 101:11815–11820. [CrossRef]
  • Mergny J.L., Riou J.F., Mailliet P., Teulade-Fichou M.P., Gilson E., Natural and pharmacological regulation of telomerase, Nucleic Acids Res. (2002) 30:839–865. [CrossRef] [PubMed]
  • Nair V.K., Kung H.J., Marek’s disease virus oncogenicity: molecular mechanisms, in: Davison F., Nair V. (Eds.), Marek’s disease, an evolving problem, Elsevier Academic Press, London, 2004.
  • Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S., Marek’s disease virus: from miasma to model, Nat. Rev. Microbiol. (2006) 4:283–294. [CrossRef] [PubMed]
  • Parcells M.S., Anderson A.S., Cantello J.L., Morgan R.W., Characterization of Marek’s disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames, J. Virol. (1994) 68:8239–8253. [PubMed]
  • Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K., Oncogenicity of virulent Marek’s disease virus cloned as bacterial artificial chromosomes, J. Virol. (2004) 78:13376–13380. [CrossRef] [PubMed]
  • Ross N., O’Sullivan G., Rothwell C., Smith G., Burgess S.C., Rennie M., et al., Marek’s disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek’s disease lymphomas, J. Gen. Virol. (1997) 78:2191–2198. [PubMed]
  • Rudolph J., Seyboldt C., Granzow H., Osterrieder N., The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M, J. Virol. (2002) 76:2952–2963. [CrossRef] [PubMed]
  • Schat K.A., Chen C.L., Calnek B.W., Char D., Transformation of T-lymphocyte subsets by Marek’s disease herpesvirus, J. Virol. (1991) 65:1408–1413. [PubMed]
  • Schumacher D., Tischer B.K., Fuchs W., Osterrieder N., Reconstitution of Marek’s disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant, J. Virol. (2000) 74:11088–11098. [CrossRef] [PubMed]
  • Shay J.W., Bacchetti S., A survey of telomerase activity in human cancer, Eur. J. Cancer (1997) 33:787–791. [CrossRef] [PubMed]
  • Shay J.W., Wright W.E., Telomerase: a target for cancer therapeutics, Cancer Cell. (2002) 2:257–265. [CrossRef] [PubMed]
  • Shkreli M., Dambrine G., Soubieux D., Kut E., Rasschaert D., Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek’s disease virus-induced lymphomagenesis, J. Virol. (2007) 81:4848–4857. [CrossRef] [PubMed]
  • Taylor H.A., Delany M.E., Ontogeny of telomerase in chicken: impact of downregulation on pre- and postnatal telomere length in vivo, Dev. Growth Differ. (2000) 42:613–621. [CrossRef] [PubMed]
  • Tischer B.K., von Einem J., Kaufer B., Osterrieder N., Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli, Biotechniques (2006) 40:191–197. [CrossRef] [PubMed]
  • Trapp S., Parcells M.S., Kamil J.P., Schumacher D., Tischer B.K., Kumar P.M., et al., A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis, J. Exp. Med. (2006) 203:1307–1317. [CrossRef] [PubMed]
  • Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F., The genome of a very virulent Marek’s disease virus, J. Virol. (2000) 74:7980–7988. [CrossRef] [PubMed]
  • Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W., Telomerase activity in human germline and embryonic tissues and cells, Dev. Genet. (1996) 18:173–179. [CrossRef] [PubMed]
  • Yunis R., Jarosinski K.W., Schat K.A., Association between rate of viral genome replication and virulence of Marek’s disease herpesvirus strains, Virology (2004) 328:142–150. [CrossRef] [PubMed]
  • Zakian V.A., Telomeres: beginning to understand the end, Science (1995) 270:1601–1607. [CrossRef] [PubMed]